Liu Zhiyi, Xiu Guanghui
Department of Intensive Care Unit, Affiliated Hospital of Yunnan University (the Second People's Hospital of Yunnan Province), Kunming 650021, Yunnan, China.
Clinical Medical College of Dali University, Dali 671000, Yunnan, China. Corresponding author: Xiu Guanghui, Email:
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024 Aug;36(8):882-886. doi: 10.3760/cma.j.cn121430-20231117-00988.
Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection, with increasing mortality as septic shock and organ failure progress. Mechanisms such as vascular endothelial dysfunction, microcirculatory disorders, coagulation abnormalities, immune suppression, mitochondrial damage, cell pyroptosis, ferroptosis, endoplasmic reticulum stress, and autophagy play crucial roles in organ dysfunction and death caused by sepsis. Concurrently, the imbalance of the gut microbiota also plays an undeniable role in the development of sepsis, with recent studies demonstrating a close connection between the gut microbiome and sepsis. Thus, how to improve the prognosis of patients with sepsis by reconstructing gut microbiota has become a focus of interest for critical care physicians. This article reviews the research progress on the correlation between gut microbiota and sepsis, providing clinical physicians with more therapeutic strategies to improve patient prognosis.
脓毒症是由宿主对感染的失调反应引起的危及生命的器官功能障碍,随着脓毒性休克和器官衰竭的进展,死亡率不断上升。血管内皮功能障碍、微循环障碍、凝血异常、免疫抑制、线粒体损伤、细胞焦亡、铁死亡、内质网应激和自噬等机制在脓毒症所致的器官功能障碍和死亡中起关键作用。同时,肠道微生物群的失衡在脓毒症的发生发展中也起着不可忽视的作用,最近的研究表明肠道微生物组与脓毒症之间存在密切联系。因此,如何通过重建肠道微生物群来改善脓毒症患者的预后已成为重症监护医生关注的焦点。本文综述了肠道微生物群与脓毒症相关性的研究进展,为临床医生提供更多改善患者预后的治疗策略。